HRAS and renal carcinoma: We have recently demonstrated that calcineurin inhibitors (CNIs) can promote rapid progression of human renal cancer through the overexpression of VEGF [22], [23]; and H-Ras and PKC may act as critical intermediary signaling molecules for CNI-induced VEGF overexpression [22], [24].